• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIP; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIP; PROTHROMBIN TIME TEST Back to Search Results
Model Number 99008G2
Device Problems Improper or Incorrect Procedure or Method (2017); Low Test Results (2458)
Patient Problems Death (1802); Hemoptysis (1887); Low Blood Pressure/ Hypotension (1914); Overdose (1988)
Event Date 01/20/2014
Event Type  Death  
Event Description
Caller alleged discrepant low inratio inr result in comparison to the laboratory result.Pt is a (b)(6) old male who was recently hospitalized on (b)(6) 2014 for effusion and lung mass and diagnosed with metastatic small cell lung carcinoma.On (b)(6) 2014 at 5:15pm, the pt's inratio inr result was 2.8 and warfarin 3mg was administered.Reportedly, the finger was "milked" after the finger stick and the sample was not immediately applied.The pt's therapeutic was 2.0 - 3.0.At 8:15pm, the pt experienced what was described as "massive hemoptysis".The pt was intubated while en route to the emergency room.The laboratory inr at 10:40pm was 7.6, hemoglobin = 12.2 and hematocrit = 37.5 (prior to blood transfusion).The pt was hospitalized on a ventilator in icu, administered vitamin k, 3 units of fresh frozen plasma (ffp), 2 units of blood, antibiotics and pressors as needed for hypotension.Ct scan of the brain revealed no acute changes.Ct scan of the chest revealed no pulmonary embolism (pe) but lung mass and possible bilateral process.After pt treatment, the laboratory inr was 1.8.On (b)(6) 2014 due to the pt's poor prognosis, terminal cancer and his wishes to not have to go through further invasive medical care, the pt was placed on a morphine drip and the pressors (propofol) was discontinued.The pt's aicd was turned to "no shock", the pt was extubated and expired at 6:47 pm.No additional information was provided.
 
Manufacturer Narrative
Investigation pending.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIP
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
san diego CA
Manufacturer Contact
ya-ling king
9975 summers ridge rd
san diego, CA 92121
8588052084
MDR Report Key3678573
MDR Text Key4261904
Report Number2027969-2014-00135
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K110212
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 01/23/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number99008G2
Device Lot Number324810
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/23/2014
Initial Date FDA Received02/19/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
AMIODARONE HCL 200MG DAILY; ASPIRIN 81MG DAILY; INRATIO 2 PT/INR PRO MONITOR SN (B)(4) WARFARIN; COREG 6.25MG TWICE A DAY; LASIX 60MG DAILY DATE OF TX (B)(6) 2014; LANOXIN 0.125MG DAILY; CAPTOPRIL 6.25MG TWICE A DAY
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age67 YR
-
-